Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Villalba

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2004
What came first: PKCtheta or the immune synapse?Martin Villalba
Immunological Reviews|April 3, 2003
Protein kinase C-theta (PKCtheta): it's all about location, location, locationAmnon Altman, Martin Villalba
Frontiers in Immunology|June 20, 2022
From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity ImprovementLoïs Coënon, Martin Villalba
Journal of Biochemistry|December 11, 2002
Protein kinase C-theta (PKC theta): a key enzyme in T cell life and deathAmnon Altman, Martin Villalba
Current Cancer Drug Targets|August 22, 2002
Protein kinase C-theta (PKCtheta), a potential drug target for therapeutic intervention with human T cell leukemiasMartin Villalba, Amnon Altman
Scientific Reports|April 6, 2019
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cellsNerea Allende-Vega, Martin Villalba
Journal of Molecular Medicine (Berlin, Germany)|August 3, 2005
Molecular targets in spinal cord injuryStefan Klussmann, Ana Martin-Villalba
Neurosurgery|June 1, 2007
Spinal cord injuries entering the Fas(t) laneElizabeth Letellier, Ana Martin-Villalba
Journal of Cellular Physiology|August 19, 2009
Sensing invasion: cell surface receptors driving spreading of glioblastomaMarcin Teodorczyk, Ana Martin-Villalba
Current Opinion in Neurobiology|December 16, 2016
Adult NSC diversity and plasticity: the role of the nicheEnric Llorens-Bobadilla, Ana Martin-Villalba
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2004
What came first: PKCtheta or the immune synapse?Martin Villalba
Immunological Reviews|April 3, 2003
Protein kinase C-theta (PKCtheta): it's all about location, location, locationAmnon Altman, Martin Villalba
Frontiers in Immunology|June 20, 2022
From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity ImprovementLoïs Coënon, Martin Villalba
Journal of Biochemistry|December 11, 2002
Protein kinase C-theta (PKC theta): a key enzyme in T cell life and deathAmnon Altman, Martin Villalba
Current Cancer Drug Targets|August 22, 2002
Protein kinase C-theta (PKCtheta), a potential drug target for therapeutic intervention with human T cell leukemiasMartin Villalba, Amnon Altman
Scientific Reports|April 6, 2019
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cellsNerea Allende-Vega, Martin Villalba
Journal of Molecular Medicine (Berlin, Germany)|August 3, 2005
Molecular targets in spinal cord injuryStefan Klussmann, Ana Martin-Villalba
Neurosurgery|June 1, 2007
Spinal cord injuries entering the Fas(t) laneElizabeth Letellier, Ana Martin-Villalba
Journal of Cellular Physiology|August 19, 2009
Sensing invasion: cell surface receptors driving spreading of glioblastomaMarcin Teodorczyk, Ana Martin-Villalba
Current Opinion in Neurobiology|December 16, 2016
Adult NSC diversity and plasticity: the role of the nicheEnric Llorens-Bobadilla, Ana Martin-Villalba
Pageof 14